Solid organ transplantation. Immunologic theory and immunosuppressive strategy

Immunology and Allergy Clinics of North America

Volumn 16, Issue 2, 1996, Pages 221-242

  Kahan, B D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 6; METHYLPREDNISOLONE; MIZORIBINE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS;

ALLOGRAFT; ALLOIMMUNITY; B LYMPHOCYTE; CYTOTOXIC LYMPHOCYTE; DRUG POTENTIATION; DRUG SELECTIVITY; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HLA SYSTEM; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW;

EID: 0030002568     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70245-9     Document Type: Article

References (70)

1. D. Abramowicz L. Schandene M. Goldman Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients Transplantation 47 1989 606
2. G.J. Agostino B.D. Kahan R.H. Kerman Suppression of mixed leukocyte culture using leukocytes from normal individuals uremic patients and allograft recipients Transplantation 34 1982 367
3. P.L. Amlot J.P. Castaigne P. Sweny A chimeric CD7 monoclonal antibody (SDZ CHH 380) for organ transplant prophylaxis Transplant Immunol Letter 7 1991 3
4. R.E. Billingham L. Brent P.B. Medawar Actively acquired tolerance of foreign cells Nature 172 1953 603
5. Y. Brewer A. Palmer D. Taube Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejection Lancet 2 8669 1989 935
6. R.L. Brinster H.Y. Chen M.E. Trumbauer Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs Proc Natl Acad Sci USA 82 1985 4438
7. R. Ceppellini E.S. Curtoni P.L. Mattiuz Histocompatibility Testing 1967 1967 Munksgaard Copenhagen 149
8. L. Chatenoud C. Ferran A. Reuter Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-γ N Engl J Med 320 1989 1420
9. A.S. Chong A. Finnegan X. Jiang Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation Transplantation 55 1993 1361
10. D.V. Cramer F.A. Chapman B.D. Jaffee The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat Transplantation 53 1992 303
11. N. Damle N. Mohagheghpour E. Engleman Soluble antigen primed inducer T cells activate antigen-specific suppressor T cells in the absence of antigen-pulsed accessory cells: Phenotypic definition of suppressor-inducer and suppressor-effector cells J Immunol 132 1984 644
12. W.C. Fanslow K.N. Clifford L.S. Park Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 Receptor J Immunol 147 1991 535
13. L.D. Felton G.H. Bailey Immunological characteristics of water-insoluble protein in type I anti-pneumococcus sera J Immunol 11 1926 197
14. E.V. Fedoseyeva Y. Li B. Huey Inhibition of interferon-γ-mediated immune functions by oligonucleotides. Suppression of human T cell proliferation by downregulation of IFN-gamma-induced ICAM-1 and Fc-receptor on accessory cells Transplantation 57 1994 606
15. P.J. Fink H.G. Rammensee M.J. Bevan Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them J Immunol 133 1984 1775
16. P.R. Fink R. Shimonkevitz M. Bevan Veto cells Annu Rev Immunol 6 1988 115
17. D.F. Fiorentino M.W. Bond T.R. Mosmann Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med 170 1989 2081
18. G. Fischer B. Wittmann-Liebold K. Lang Cyclophilin and peptidyl-prolyl cistrans isomerase are probably identical proteins Nature 337 1989 476
19. M. Hasek Vegetavni hybridisace zivocichy spoijenim krevnich obehu v embryonalnim wyvojhi Cesk Biol 2 1953 265
20. W.R. Herzog B. Zanker E. Irschick Selective reduction of donor-specific cytotoxic T-Iymphocyte precursors in patients with a well-functioning kidney allograft Transplantation 43 1987 384
21. b) by a mouse γç T cell receptor Cell 62 1990 549
22. S.L. Jones-Youngblood K. Wieties J. Forman Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance J Immunol 144 1990 1187
23. B.D. Kahan J. Grevel Overview: Optimization of cyclosporine therapy in renal ransplantation by a pharmacokinetic strategy Transplantation 46 1988 631
24. B.D. Kahan Cyclosporine N Engl J Med 321 1989 1725
25. B.D. Kahan R.H. Kerman C.T. Van Buren Clinical outcome in 36 patients after at least one and up to five years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor Transplant Proc 21 1989 1579
26. 3H-based specific monoclonal antibody assay on whole blood samples with the fluorescence polarization nonspecific immunoassay on serum samples for diagnosis of adverse events in renal transplant patients Transplant Proc 22 1990 1274
27. B.D. Kahan Transplantation Timeline Transplantation 51 1991 1
28. B.D. Kahan J.Y. Chang S.N. Seghal Preclinical evaluation of a new potent immunosuppressive agent, rapamycin Transplantation 52 1991 185
29. B.D. Kahan S. Gibbons N. Tejpal Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro Transplantation 51 1991 232
30. J.W. Kappler N. Roehm P. Marrack T cell tolerance by clonal elimination in the thymus Cell 49 1987 273
31. S.J. Knechtle J.D. Pirsch M. Groshek OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation Transplant Proc 23 1991 1581
32. R.J. Knight R.H. Kerman M. Welsh D. Golden L. Schoenberg Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immuno-suppressive therapy Transplantation 51 1991 355
33. 2b monoclonal antibody (BMA 031) directed toward the human α/β-T cell receptor Transplantation 57 1994 1581 1588
34. H. Koyama M. Tsuji Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin a potent inhibitor of purine biosynthesis in mammalian cells Biochem Pharmacol 32 1983 3527
35. K. Landsteiner M.W. Chase Studies on sensitization of animals with simple chemical compounds; IV J Exp Med 66 1937 337
36. A. Lanzavecchia Identifying strategies for immune intervention Science 260 1993 937
37. D. Lo L.C. Burkly G. Widera Diabetes and tolerance in transgenic mice expressing class 11 MHC molecules in pancreatic beta cells Cell 53 1988 159
38. D. Lo L.C. Burkly R.A. Falvell Tolerance in transgenic mice expressing class 11 major histocompatibility complex on pancreatic acinar cells J Exp Med 170 1989 87
39. J.M. Main R.T. Prehn Fate of skin homografts in x-irradiated mice treated with homologous marrow J Natl Cancer Inst 19 1957 1053
40. D.L. Meuller M.K. Jenkins R.H. Schwartz Clonal expansion is functional clonal inactivation: A costimulatory signalling pathway determines the antigen receptor occupancy Annu Rev Immunol 7 1989 445
41. W. Moolenaar J.A. Brujin E. Schrama T-cell receptors and ICAM-1 expression in renal allografts during rejection Transpl Int 4 1991 140
42. R.E. Morris E.G. Hoyt M. Murphy Mycophenolic acid morphoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T and B cell purine systems Transplant Proc 22 1990 1659
43. M.G. Murgia S. Jordan B.D. Kahan The side effect profile of sirolimus Kidney Int 49 1996 209
44. J.B. Murphy Studies in tissue specificity: III J Exp Med 19 1914 513
45. G.J. Nossal Immunologic tolerance: Collaboration between antigen and lymphokine Science 245 1989 147
46. Ortho Multicenter Transplant Study Group A randomized clinical trial of OKT3 onoclonal antibody for acute rejection of cadaveric renal transplants N Engl J Med 313 1985 337
47. R.D. Owen Immunogenetic consequences of vascular anastomoses between bovine twins Science 102 1945 400
48. K. Rolles A.K. Burroughs B.R. Davidson Donor-specific bone marrow infusion after orthotopic liver transplantation Lancet 343 1994 263
49. F. Sanfilippo W.K. Vaughn W.M. LeFor Multivariant analysis of risk factors in cadaver donor kidney transplantation Transplantation 42 1986 28
50. R.H. Schwartz Acquisition of immunologic self-tolerance Cell 57 1989 1073
51. Y. Shimizu D.E. Geraghty B.H. Koller Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells Proc Natl Acad Sci USA 85 1988 227
52. N.H. Sigal F.J. Dumont Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction Ann Rev Immunol 10 1992 519
53. R.L. Simmons D.M. Canafax M. Strand Management and prevention of cyclosporine nephrotoxicity after renal transplantation: Use of low doses of cyclosporine, azathioprine, and prednisone Transplant Proc 17 1985 266
54. S. Slavin S. Strober Z. Fuks Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts J Exp Med 146 1977 34
55. J.P. Soullilou D. Cantarovich B. Le Mauf Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts N Engl J Med 322 1990 1175
56. T.E. Starzl A.J. Demetris N. Murase Cell migration, chimerism, and graft acceptance Lancet 339 1992 1579
57. S.M. Stepkowski Y. Tu T.P. Condon Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies Transplant Proc 27 1995 113
58. A.M. Stoppa D. Maraninchi D. Blais Anti-LFA 1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host disease Transpl Int 4 1991 3
59. S. Strober H. Dhillon M. Schubert Acquired immune tolerance to cadaveric renal allografts N Engl J Med 321 1989 28
60. M.B. Sulzburger Hypersensitiveness to asphenamine in guinea pigs: Experiments in prevention and in densitization Arch Dermatol Syph 20 1929 669
61. N. Takahashi T. Hayano M. Suzuki Peptidyl-prolyl cis-trans isomerase is the cyclosporine A-binding protein cyclophilin Nature 337 1989 473
62. T. Takeuchi R.P. Lowry B. Konilerzny Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance Transplantation 53 1992 1281
63. B. Toyonaga T.W. Mak Genes of the T-cell antigen receptor in normal and malignant T cells Annu Rev Immunol 5 1987 585
64. H. Van Boehmer M. Nabholz J. Sprent Hemopoietic reconstitution obtained in F1 hybrids by grafting of parental marrow cells Transplant Proc 8 1976 355
65. A. Vathsala T.-C. Chou B.D. Kahan Analysis of the interactions of immuno-suppressive drugs with cyclosporine in inhibiting DNA proliferation Transplantation 49 1990 463
66. T.H. Waid B.A. Lucas J.S. Thompson Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients Transplantation 53 1992 80
67. S. Webb C. Morris J. Sprent Extrathymic tolerance of mature T cells: Clonal elimination as consequence of immunity Cell 63 1990 1249
68. S.L. Wee D.M. Stroka F.I. Preffer The effects of OKT4A monoclonal antibody on cellular immunity of nonhuman primate renal allograft recipients Transplantation 53 1992 501
69. K.J. Wieder G. Walz B. Zanker Physiologic signaling in normal human T-cells: mRNA phenotyping by northern blot analysis and reverse transcription-polymerase chain reaction Cell Immunol 128 1990 41
70. M.F.A. Woodruff L.O. Simpson Induction of tolerance to skin homografts in rats by injection of cells from prospective donors soon after birth Br J Exp Pathol 36 1995 494